Advances in understanding of bile acid diarrhea

References

• Hofmann AF, Small DM. Detergent properties of bile salts: correlation with physiological function. Annu. Rev. Med. 18, 333–376 (1967).
   PubMed Web of Science ®Google Scholar
• Rao AS, Wong B, Camilleri M et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 139, 1549–1558 (2010).
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241–259 (2006).
   PubMed Web of Science ®Google Scholar
• Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: cholerhetic enteropathy. Gastroenterology 52, 752–757 (1967).
   PubMed Web of Science ®Google Scholar
• Martinez-Augustin O, Sanchez de Medina F. Intestinal bile acid physiology and pathophysiology. World J. Gastroenterol. 14, 5630–5640 (2008).
   PubMed Web of Science ®Google Scholar
• Halilbasic E, Claudel T, Trauner M. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J. Hepatol. 58, 155–168 (2013).
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126, 322–342 (2004).
   PubMed Web of Science ®Google Scholar
• Ballatori N, Li N, Fang F, Boyer JL, Christian WV, Hammond CL. OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids. Front Biosci. (Landmark Ed). 14, 2829–2844 (2009).
   PubMed Web of Science ®Google Scholar
• Wedlake L, A’Hern R, Russell D et al. Systematic Review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 30, 707–717 (2009).
   PubMed Web of Science ®Google Scholar
• Mekhjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J. Clin. Invest. 50, 1569–1577 (1971).
   PubMed Web of Science ®Google Scholar
• Bampton PA, Dinning PG, Kennedy ML et al. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am. J. Physiol. 282, G443–G449 (2002).
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Gaginella TS, Carlson GL et al. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J. Lab. Clin. Med. 94, 661–674 (1979).
   PubMed Web of Science ®Google Scholar
• Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J. Clin. Invest. 84, 1056–1062 (1989).
   PubMed Web of Science ®Google Scholar
• Conley DR, Coyne MJ, Bonorris GG, Chung A, Schoenfield LJ. Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit. Am. J. Dig. Dis. 21, 453–458 (1976).
   PubMedGoogle Scholar
• Alrefai WA, Saksena S, Tyagi S, Gill RK, Ramaswamy K, Dudeja PK. Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells. Dig. Dis. Sci. 52, 1270–1278 (2007).
   PubMed Web of Science ®Google Scholar
• Ao M, Sarathy J, Domingue J, Alrefai WA, Rao MC. Chenodeoxycholic acid stimulates Cl- secretion via cAMP signaling and increases cystic fibrosis transmembrane conductance regulator phosphorylation in T84 cells. Am. J. Physiol. 305, C447–C456 (2013).
   PubMed Web of Science ®Google Scholar
• Peregrin AT, Ahlman H, Jodal M, Lundgren O. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Br. J. Pharmacol. 127, 887–894 (1999).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Murphy R. Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid induced secretion of fluid and mucus in the rabbit colon. Dig. Dis. Sci. 27, 865 869 (1982).
   PubMed Web of Science ®Google Scholar
• Yamada T, Inui A, Hayashi N, Fujimura M, Fujimiya M. Serotonin stimulates endotoxin translocation via 5-HT3 receptors in the rat ileum. Am. J. Physiol. 284, G782–G788 (2003).
   PubMed Web of Science ®Google Scholar
• Kruis W, Haddad A, Phillips SF. Chenodeoxycholic and ursodeoxycholic acids alter motility and fluid transit in the canine ileum. Digestion 34, 185–195 (1986).
   PubMed Web of Science ®Google Scholar
• Kirwan WO, Smith AN, Mitchell WD, Falconer JD, Eastwood MA. Bile acids and colonic motility in the rabbit and the human. Gut 16, 894–902 (1975).
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Poley JR. Cholestyramine treatment of diarrhea associated with ileal resection. N. Engl. J. Med. 281, 397–402 (1969).
   PubMed Web of Science ®Google Scholar
• Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 62, 918–934 (1972).
   PubMed Web of Science ®Google Scholar
• Poley JR, Hofmann AF. Role of fat maldigestion in pathogenesis of steatorrhea in ileal resection. Fat digestion after two sequential test meals with and without cholestyramine. Gastroenterology 71, 38–44 (1976).
   PubMed Web of Science ®Google Scholar
• Williams AJ, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. Gut 32, 1004–1006 (1991).
   PubMed Web of Science ®Google Scholar
• Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br. Med. J. 290, 665–668 (1985).
   PubMed Web of Science ®Google Scholar
• Fernández-Bañares F, Esteve M, Salas A et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102, 2520–2528 (2007).
   PubMed Web of Science ®Google Scholar
• Wildt S, Nørby Rasmussen S, Lysgård Madsen J, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test. Scand. J. Gastroenterol. 38, 826–830 (2003).
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol. Motil. 24, 983 e538 (2012).
   Web of Science ®Google Scholar
• Limsui D, Pardi DS, Camilleri M et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm. Bowel Dis. 13, 175–181 (2007).
   PubMed Web of Science ®Google Scholar
• Walters JR, Pattni SS. Managing bile acid diarrhoea. Ther. Adv. Gastroenterol. 3, 349–357 (2010).
   PubMedGoogle Scholar
• Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab. 37, 90–96 (2011).
   PubMed Web of Science ®Google Scholar
• Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabetologia 13, 187–193 (1977).
   PubMed Web of Science ®Google Scholar
• Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet. Med. 15, 651–656 (1998).
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Sharpstone DR, Francis N et al. Intestinal inflammation, ileal structure and function in HIV. AIDS 10, 1385–1391 (1996).
   PubMed Web of Science ®Google Scholar
• Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260, 530–536 (2006).
   PubMed Web of Science ®Google Scholar
• Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, Le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin. Gastroenterol. Hepatol. 7, 1189–1194 (2009).
   PubMed Web of Science ®Google Scholar
• Montagnani M, Love MW, Rössel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand. J. Gastroenterol. 36, 1077–1080 (2001).
   PubMed Web of Science ®Google Scholar
• Montagnani M, Abrahamsson A, Gälman C et al. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J. Gastroenterol. 12, 7710–7714 (2006).
   PubMed Web of Science ®Google Scholar
• Sciarretta G, Fagioli G, Furno A et al. 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 28, 970–975 (1987).
   PubMed Web of Science ®Google Scholar
• Sadik R, Abrahamsson H, Ung KA, Stotzer PO. Accelerated regional bowel transit and overweight shown in idiopathic bile acid malabsorption. Am. J. Gastroenterol. 99, 711–718 (2004).
   PubMed Web of Science ®Google Scholar
• Valdés Olmos R, den Hartog Jager F, Hoefnagel C, Taal B. Effect of loperamide and delay of bowel motility on bile acid malabsorption caused by late radiation damage and ileal resection. Eur J Nucl. Med. 18, 346–350 (1991).
   PubMedGoogle Scholar
• Yeoh EK, Horowitz M, Russo A, Muecke T, Robb T, Chatterton BE. Gastrointestinal function in chronic radiation enteritis--effects of loperamide-N-oxide. Gut 34, 476–482 (1993).
   PubMed Web of Science ®Google Scholar
• Bajor A, Kilander A, Fae A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol. 8, 397–403 (2006).
   Google Scholar
• Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and long term effects in the intestine. Scand. J. Gastroenterol. 45, 645–664 (2010).
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson PJ et al. A klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 140, 1934–1942 (2011).
   PubMed Web of Science ®Google Scholar
• Kawamata Y, Fujii R, Hosoya M et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435–9440 (2003).
   PubMed Web of Science ®Google Scholar
• Ward JB, Mroz MS, Keely SJ. The bile acid receptor, TGR5, regulates basal and cholinergic-induced secretory responses in rat colon. Neurogastroenterol. Motil. 25, 708–711 (2013).
   PubMed Web of Science ®Google Scholar
• Poole DP, Godfrey C, Cattaruzza F et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol. Motil. 22, 814–25 (2010)
   PubMed Web of Science ®Google Scholar
• Hov JR, Keitel V, Laerdahl JK et al. Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS ONE 5, e12403 (2010).
   PubMed Web of Science ®Google Scholar
• Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr. Mol. Med. 10, 579–595 (2010).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol. Motil. 23, 995–999, 458 (2011).
   PubMed Web of Science ®Google Scholar
• Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N. Engl. J. Med. 367, 1626–1635 (2012).
   PubMed Web of Science ®Google Scholar
• Galatola G, Jazrawi RP, Bridges C, Joseph AE, Northfield TC. Direct measurement of first-pass ileal clearance of a bile acid in humans. Gastroenterology 100, 1100–1105 (1991).
   PubMed Web of Science ®Google Scholar
• van Tilburg AJ, de Rooij FW, van den Berg JW, Kooij PP, van Blankenstein M. The selenium-75-homocholic acid taurine test re-evaluated: combined measurement of fecal selenium-75 activity and 3 alpha-hydroxy bile acids in 211 patients. J. Nucl. Med. 32, 1219–1224 (1991).
   PubMed Web of Science ®Google Scholar
• Sciarretta G, Furno A, Mazzoni M, Malaguti P. Post-cholecystectomy diarrhea: evidence of bile acid malabsorption assessed by SeHCAT test. Am. J. Gastroenterol. 87, 1852–1854 (1992).
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Nyhlin H, Truedsson H. Bile acid malabsorption demonstrated by SeHCAT in chronic diarrhoea, with special reference to the impact of cholecystectomy. Scand. J. Gastroenterol. 23, 1187–1194 (1988).
   PubMed Web of Science ®Google Scholar
• Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Sanders DS. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand. J. Gastroenterol. 46, 818–822 (2011).
   PubMed Web of Science ®Google Scholar
• Al-Hadrani A, Lavelle-Jones M, Kennedy N, Neill G, Sutton D, Cuschieri A. Bile acid malabsorption in patients with postvagotomy diarrhoea. Ann. Chir. Gynaecol. 81, 351–353 (1992).
   PubMedGoogle Scholar
• Ladas SD, Isaacs PE, Quereshi Y, Sladen G. Role of the small intestine in postvagotomy diarrhea. Gastroenterology 85, 1088–1093 (1983).
   PubMed Web of Science ®Google Scholar
• Fort JM, Azpiroz F, Casellas F, Andreu J, Malagelada JR. Bowel habit after cholecystectomy: physiological changes and clinical implications. Gastroenterology 111, 617–622 (1996).
   PubMed Web of Science ®Google Scholar
• Phillips SF. Diarrhea after cholecystectomy: if so, why? Gastroenterology 111, 816–818 (1996).
   PubMed Web of Science ®Google Scholar
• Bisschop PH, Bandsma RH, Stellaard F et al. Low-fat, high-carbohydrate and high-fat, low-carbohydrate diets decrease primary bile acid synthesis in humans. Am. J. Clin. Nutr. 79, 570–576 (2004).
   PubMed Web of Science ®Google Scholar
• Li T, Matozel M, Boehme S et al. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53, 996–1006 (2001).
   Google Scholar
• Jonkers IJ, Smelt AH, Princen HM et al. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia. J. Nutr. 136, 987–991 (2006).
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487, 104–108 (2012).
   PubMed Web of Science ®Google Scholar
• Laue H, Denger K, Cook AM. Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU Appl. Environ. Microbiol. 63, 2016–2021 (1997).
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Avigan J, Goodman DS, Sjövall J, Steinberg DJ. The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. Clin. Invest. 44, 1754–1765 (1965).
   Google Scholar
• Scarpello JH, Hodgson E, Howlett HC. Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus. Diabet. Med. 15, 651–656 (1998).
   PubMed Web of Science ®Google Scholar
• Caspary WF, Zavada I, Reimold W, Deuticke U, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabetologia 13, 187–193 (1977).
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlström A, Felin J et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225–235 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y. Gut microbiota composition modifies fecal metabolic profiles in mice. J. Proteome Res. 12, 2987–2999 (2013).
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids, and gut microbiota: Unraveling a complex relationship. Gut Microbes 4(5) (2013).
   PubMed Web of Science ®Google Scholar
• Ou J, Carbonero F, Zoetendal EG et al. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. 98, 111–120 (2013).
   PubMed Web of Science ®Google Scholar
• Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62, 531–539 (2013).
   PubMed Web of Science ®Google Scholar
• Duboc H, Rainteau D, Rajca S et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 513–520 (2012).
   PubMed Web of Science ®Google Scholar
• Kakiyama G, Pandak WM, Gillevet PM et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949–955 (2013).
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin. Microbiol. Infect. 19, 338–348 (2013).
   PubMed Web of Science ®Google Scholar
• Ridaura VK, Faith JJ, Rey FE et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
   PubMed Web of Science ®Google Scholar
• Camilleri M. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? The con argument. Clin. Gastroenterol. Hepatol. 8, 129–132 (2010).
   Web of Science ®Google Scholar
• Surowiec D, Kuyumjian AG, Wynd MA et al. Past, present, and future therapies for Clostridium difficile-associated disease. Ann. Pharmacother. 40, 2155–2163 (2006).
   PubMed Web of Science ®Google Scholar
• Weiss K. Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer. Int. J. Antimicrob. Agents 33, 4–7 (2009).
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin. Gastroenterol. Hepatol. 11(10), 1232–1239 (2013).
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson P et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin. Gastroenterol. Hepatol. 10, 1009–1015 (2012).
   PubMed Web of Science ®Google Scholar
• Shin A, Camilleri M, Vijayvargiya P et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11(10), 1270–1275 e1 (2013).
   PubMed Web of Science ®Google Scholar
• Pattni SS, Brydon WG, Dew T, Walters JR. Fibroblast growth factor 19 and 7α-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin. Transl. Gastroenterol. 3, e18 (2012).
   Web of Science ®Google Scholar
• Pattni SS, Brydon WG, Dew T et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment. Pharmacol. Ther. 38(8), 967–976 (2013).
   PubMed Web of Science ®Google Scholar
• Camilleri M, Acosta A. Invited commentary: fibroblast growth factor 19 in patients with bile acid diarrhea: a prospective comparison of FGF19 serum assay and SeHCAT retention by Pattni et al. Aliment. Pharmacol. Ther. ( In press).
   Google Scholar
• Odunsi-Shiyanbade ST, Camilleri M, McKinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol. 8, 159–165 (2010).
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson PJ et al. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig. Dis. Sci. 57, 1222–1226 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang JH, Nolan JD, Kennie SL et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am. J. Physiol. 304, G940–G948 (2013).
   Google Scholar
• Johnston IM, Nolan JD, Dew T, Shapiro D, Walters JRF. A new therapy for chronic diarrhea? A proof of concept study of the FXR agonist obeticholic acid in patients with primary bile acid diarrhea. Gastroenterology 144( Suppl. 144), S60 (2013).
   Google Scholar
• Keating N, Mroz MS, Scharl MM et al. Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells. J. Cell Mol. Med. 13, 2293–2303 (2009).
   PubMed Web of Science ®Google Scholar
• Mroz MS, Keating N, Ward J, et al. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo. Gut doi:10.1136/gutjnl-2013–305088 (2013) ( Epub ahead of print).
   Google Scholar
• Nolan JD, Johnston IM, Walters JR. Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective. Expert Rev. Gastroenterol. Hepatol. 7, 49–56 (2013).
   PubMed Web of Science ®Google Scholar
• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin. Gastroenterol. Hepatol. 10, 712–721 (2012).
   PubMed Web of Science ®Google Scholar
• Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am. J. Gastroenterol. 107, 991–1000 (2012).
   PubMed Web of Science ®Google Scholar
• Omar MI, Alexander CE. Drug treatment for faecal incontinence in adults. Cochrane Database Syst. Rev. (6), CD002116 (2013).
   Google Scholar